Market Overview:
The global isoliquiritigenin market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in the market can be attributed to factors such as rising demand for isoliquiritigenin from various applications, increasing research and development activities for isoliquiritigenin, and growing awareness about the benefits of isoliquiritigenin. However, factors such as high cost of production and limited availability could restrain the growth of this market.
Product Definition:
Isoliquiritigenin is a flavonoid found in licorice. It has anti-inflammatory and antiviral properties.
Less Than 98%:
Isoliquiritigenin is a bioactive compound, extracted from plant ginseng. It has the ability to inhibit angiogenesis and metastasis of tumor by blocking the formation of new blood vessels by endothelial cells. The compound also possesses anti-inflammatory properties that can be utilized in treating inflammatory skin diseases such as atopic dermatitis and psoriasis through topical application.
More Than 98%:
More than 98% is a technical term used for the concentration of a flavonoid in plant extracts. More than 98% of total isoliquiritigenin content found in Chia seeds is present in the form of bound fraction on account of its hydrophobic nature. The percentage value “98” represents the weight ratio between free and bound fraction, which varies from 0.1 to 10 depending upon various factors such as extraction method, solvent type and temperature, among others.
Application Insights:
Isoliquiritigenin is widely used in the form of a dietary supplement and as an additive in the pharmaceutical industry. The antioxidant property of isoliquiritigenin has led to its extensive use as an additive in nutritional supplements. In addition, it also finds application as a food additive and preservative for various food products such as cheese, chocolate bars, juices etc.
The antimicrobial activity of isoliquiritigenin has resulted in its extensive use against bacteria including Staphylococcus aureus, Escherichia coli O157:H7 (Shiga toxin-producing E.coli), Listeria monocytogenes (listeriosis) etc., It is also used against fungal infections such as Candida albicans & Torulopsis glabrata (fungal ulcers). Other than these applications, it is also used for animal feed purposes owing to increased weight gain by animals treated with it compared to untreated animals.
Regional Analysis:
North America is anticipated to be the largest market over the forecast period owing to high product demand as a result of rising consumer awareness regarding health and well-being. The region accounted for 39.1% share in terms of revenue in 2017, which is attributed to growing geriatric population and increasing healthcare expenditure. Moreover, presence of key manufacturers such as Cargill Inc., Roquette LLC, and FMC Corporation will boost market growth over the forecast period.
Asia Pacific is expected to register significant growth due to rise in disposable income coupled with improving healthcare infrastructure leading towards economic development especially in emerging countries such as China.
Growth Factors:
- Increasing demand for natural and organic products
- Rising awareness about the health benefits of Isoliquiritigenin
- Growing popularity of herbal supplements and remedies
- Proliferation of online retail channels
- Expanding applications for Isoliquiritigenin in food, cosmetics, and pharmaceuticals
Scope Of The Report
Report Attributes
Report Details
Report Title
Isoliquiritigenin Market Research Report
By Type
Less Than 98%, More Than 98%
By Application
Antidiabetic, Antitumour, Antioxidant, Anti-Inflammatory, Antimutagenic, Antifungal
By Companies
BOC Sciences, BLDpharm, Pharmaffiliates, ChemScence, AdooQ BioScience, ApexBio Technology, EXTRASYNTHESE, Merck, Abcam, Targetmol, Ivy Fine Chemicals, Cayman Chemical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
139
Number of Tables & Figures
98
Customization Available
Yes, the report can be customized as per your need.
Global Isoliquiritigenin Market Report Segments:
The global Isoliquiritigenin market is segmented on the basis of:
Types
Less Than 98%, More Than 98%
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Antidiabetic, Antitumour, Antioxidant, Anti-Inflammatory, Antimutagenic, Antifungal
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- BOC Sciences
- BLDpharm
- Pharmaffiliates
- ChemScence
- AdooQ BioScience
- ApexBio Technology
- EXTRASYNTHESE
- Merck
- Abcam
- Targetmol
- Ivy Fine Chemicals
- Cayman Chemical
Highlights of The Isoliquiritigenin Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Less Than 98%
- More Than 98%
- By Application:
- Antidiabetic
- Antitumour
- Antioxidant
- Anti-Inflammatory
- Antimutagenic
- Antifungal
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Isoliquiritigenin Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Isoliquiritigenin is a natural compound found in plants. It has been shown to have anti-inflammatory and antioxidant properties.
Some of the major players in the isoliquiritigenin market are BOC Sciences, BLDpharm, Pharmaffiliates, ChemScence, AdooQ BioScience, ApexBio Technology, EXTRASYNTHESE, Merck, Abcam, Targetmol, Ivy Fine Chemicals, Cayman Chemical.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Isoliquiritigenin Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Isoliquiritigenin Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Isoliquiritigenin Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Isoliquiritigenin Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Isoliquiritigenin Market Size & Forecast, 2020-2028 4.5.1 Isoliquiritigenin Market Size and Y-o-Y Growth 4.5.2 Isoliquiritigenin Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Less Than 98%
5.2.2 More Than 98%
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Antidiabetic
6.2.2 Antitumour
6.2.3 Antioxidant
6.2.4 Anti-Inflammatory
6.2.5 Antimutagenic
6.2.6 Antifungal
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Isoliquiritigenin Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Isoliquiritigenin Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Less Than 98%
9.6.2 More Than 98%
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Antidiabetic
9.10.2 Antitumour
9.10.3 Antioxidant
9.10.4 Anti-Inflammatory
9.10.5 Antimutagenic
9.10.6 Antifungal
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Less Than 98%
10.6.2 More Than 98%
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Antidiabetic
10.10.2 Antitumour
10.10.3 Antioxidant
10.10.4 Anti-Inflammatory
10.10.5 Antimutagenic
10.10.6 Antifungal
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Less Than 98%
11.6.2 More Than 98%
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Antidiabetic
11.10.2 Antitumour
11.10.3 Antioxidant
11.10.4 Anti-Inflammatory
11.10.5 Antimutagenic
11.10.6 Antifungal
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Less Than 98%
12.6.2 More Than 98%
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Antidiabetic
12.10.2 Antitumour
12.10.3 Antioxidant
12.10.4 Anti-Inflammatory
12.10.5 Antimutagenic
12.10.6 Antifungal
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Less Than 98%
13.6.2 More Than 98%
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Antidiabetic
13.10.2 Antitumour
13.10.3 Antioxidant
13.10.4 Anti-Inflammatory
13.10.5 Antimutagenic
13.10.6 Antifungal
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Isoliquiritigenin Market: Competitive Dashboard
14.2 Global Isoliquiritigenin Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 BOC Sciences
14.3.2 BLDpharm
14.3.3 Pharmaffiliates
14.3.4 ChemScence
14.3.5 AdooQ BioScience
14.3.6 ApexBio Technology
14.3.7 EXTRASYNTHESE
14.3.8 Merck
14.3.9 Abcam
14.3.10 Targetmol
14.3.11 Ivy Fine Chemicals
14.3.12 Cayman Chemical